Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for political professionals · Thursday, March 28, 2024 · 699,538,739 Articles · 3+ Million Readers

www.TheCBDKlub.com Open for Business

American Diversified Holdings Corporation (ADHC) Bolsters $.15 Price Target By Unveiling Ecommerce Platform www.TheCBDKlub.com

Recent Passing of $867 Billion US Farm Bill Legalizing Hemp Paves The Way For Huge CBD Industry Grow In Excess of $22 Billion

DEL MAR, Calif., Dec. 18, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- American Diversified Holdings Corporation (OTC PINK: ADHC) today announced that the company's cannabis ecommerce platform http://www.TheCBDKLUB.com is open for business. The site currently offers unique and well-priced CBD infused beverages including tea, coffee and drink mixes.

The US Senate voted to approve a new $867 billion farm bill, and on last Wednesday it passed in Congress. This bill it will legalize the production, sale, and distribution of industrial hemp at a federal level. The Brightfield Group recently estimated that the CBD market alone could exceed $22 billion within three years by 2022.

The Hemp plant contains Cannabidiol or CBD a compound with a host of purported health benefits, and without the psychoactive effects of its chemical friend THC. The hemp industry could be worth an astonishing $22 Billion and much of that worth will come from the CBD industry. Cannabidiol or CBD is a cannabis compound that has significant medical benefits. CBD-rich cannabis is non-psychoactive or less psychoactive than THC-dominant strains making it an appealing option for many patients. Please refer to www.ProjectCBD.org for more information on how CBD can help patients and consumers alleviate the symptoms of numerous disorders and conditions.

"We are off to the races," commented ADHC. “More products and features will be added to the site in the near future. The goal of the CBD Klub is to create a community for consumers looking to embrace the benefit of this amazing compound. Obviously, much research needs to be done in the medical research community before CBD becomes a mainstream treatment but many, many people and organizations are touting the benefits of including CBD into their daily nutritional regiment. We hope to become a go to site for people’s daily CBD needs,” concluded ADHC.

Recently, Goldman Small Cap Research issued a research report on the Company. The report includes a 'speculative-buy' rating with a target price-per-share of $.15 (fifteen cents). The report provides an in-depth overview and analysis of ADHC's two operating divisions, www.AuracisMigraine.com (Migraine Bio-Device) and www.TheCBDKlub.com (Cannabis E-commerce Platform). To view the report, along with disclosures and disclaimers, visit http://www.GoldmanResearch.com. Goldman Small cap research recently wrote a report on another cannabis company PURATION (PURA) and the stock met Goldman's price target of $.26 per share

The Goldman report features an in-depth analysis of the AURACIS™ patented non-opioid pain management technology using Transcutaneous Electric Nerve Stimulation (TENS) to treat severe migraines. This procedure is derived from the OMEGA surgical procedure which has been established as extremely successful in treating severe migraines.

"This report will give shareholders and other interested parties and comprehensive picture of both our current operation business, the market environment, and our growth potential, Goldman's has resulted in a $.15 per share stock price estimate as our business develops," commented ADHC.

About Goldman Small Cap Research: Founded in 2009 by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and microcap stock research reports, articles, stock market blogs, and popular investment newsletters.

Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.

ADHC is a holding company that provides executive management, corporate governance, administrative support, financial advice, and introductions to capital sources to various micro-cap private and public companies that have proven revenues and business models.

AURACIS™ is a patented bio-device company utilizing Trans-cutaneous electric nerve stimulation (TENS) for migraine pain management. www.AuracisMigraine.com

www.TheCBDKlub.com is a unique Ecommerce platform connecting consumers, suppliers, manufacturers and growers of Cannabis with emphasis on CBD. Expected launch date is 12-18-2018.

This press release contains forward-looking statements pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements include risks and uncertainties that may cause the Company's plans to change and are in no way intended to guarantee that the Company will be successful in executing its plans. common stock currently trades on the over-the-counter under the symbol ADHC. This press release in no way constitutes any recommendation regarding the securities of ADHC or its affiliates. Any person reading this press release is advised that this release should be considered in the light of all facts and circumstances regarding the business and financial condition and prospects of ADHC, and no reference has been made that this release contains all information.

Contact:

ADHCinvestor@gmail.com
Tel: 858-259-4534

ADHC Logo.png

Powered by EIN News
Distribution channels:


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release